Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / TMO - Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. | Benzinga


TMO - Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. | Benzinga

    • Thermo Fisher Scientific to provide CAR-T manufacturing and kitting services for Galapagos' point-of-care CAR-T product candidate in the San Francisco area
    • Agreement follows previously announced collaboration with Landmark Bio for decentralized CAR-T manufacturing in the Boston area

    Mechelen, Belgium; 4 January 2024, 22:01 CET; Galapagos NV ((Euronext &amp, NASDAQ:GLPG) today announced that it has entered into a strategic collaboration agreement with Thermo Fisher Scientific, Inc. (NYSE:TMO) ("Thermo Fisher") for the decentralized manufacturing of Galapagos' point-of-care CAR-T product candidate in the San Francisco area.

    Under the terms of the agreement, Thermo Fisher will provide GMP manufacturing as well as BioServices and Specialty Logistics for Galapagos' CAR-T hemato-oncology clinical program in the San Francisco area, effective January 2024. Galapagos will initiate the technology transfer to enable Thermo Fisher's manufacturing activities. This collaboration follows Galapagos' agreement with Landmark Bio for decentralized CAR-T manufacturing in the Boston area announced in November 2023.

    "As we continue to execute on our global CAR-T expansion strategy, we are very pleased to collaborate with Thermo Fisher, a leader in accelerating life sciences research and the development of life-changing therapies," said Dr. Paul Stoffels1, CEO and Chairman of Galapagos. "Together we will establish a decentralized CAR-T manufacturing network in the San Francisco area to support the rollout of our pivotal clinical trials and enhance our market readiness. This collaboration will advance Galapagos' commitment to better meeting patient needs and making CAR-T therapies available to more patients through the rapid delivery of fit CAR-T cells."
    ?
    "This collaboration marks the start of an exciting journey to support Galapagos with their decentralized manufacturing strategy," stated Jennifer Cannon, president ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Thermo Fisher Scientific Inc
    Stock Symbol: TMO
    Market: NYSE
    Website: corporate.thermofisher.com

    Menu

    TMO TMO Quote TMO Short TMO News TMO Articles TMO Message Board
    Get TMO Alerts

    News, Short Squeeze, Breakout and More Instantly...